The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
Aim: to assess the immunogenicity and safety of CYD-tetravalent dengue vaccine (CYD-TDV) in children. Methods: comprehensive literature searches were conducted on various databases. Randomized-controlled trials on children with CYD-TDV as intervention were selected based on inclusion and exclusion c...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2017-05-01
|
| Series: | Acta Medica Indonesiana |
| Subjects: | |
| Online Access: | https://www.actamedindones.org/index.php/ijim/article/view/297 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849387571766886400 |
|---|---|
| author | Raksheeth Agarwal Mardiastuti H Wahid Oliver E Yausep Sharon Hanmy Angel Angga W Lokeswara |
| author_facet | Raksheeth Agarwal Mardiastuti H Wahid Oliver E Yausep Sharon Hanmy Angel Angga W Lokeswara |
| author_sort | Raksheeth Agarwal |
| collection | DOAJ |
| description | Aim: to assess the immunogenicity and safety of CYD-tetravalent dengue vaccine (CYD-TDV) in children. Methods: comprehensive literature searches were conducted on various databases. Randomized-controlled trials on children with CYD-TDV as intervention were selected based on inclusion and exclusion criteria. Data extracted from selected trials included safety of vaccine and immunogenicity in terms of Geometric Mean Titres (GMT) of antibodies. Results: six clinical trials were selected based on preset criteria. GMT values were obtained using 50% Plaque Reduction Neutralization Test (PRNT) and safety was semi-quantitatively assessed based on adverse effects. Additional data processing was done to obtain a better understanding on the trends among the studies. The results showed that the groups vaccinated with CYD-TDV showed higher immunogenicity against dengue virus antigens than the control groups. Safety results were satisfactory in all trials, and most severe side effects were unrelated to the vaccine. Conclusion: CYD-TDV is both effective and safe for patients in endemic regions. This gives promise for further development and large-scale research on this vaccine to assess its efficacy in decreasing dengue prevalence, and its pervasive implementation in endemic countries, such as Indonesia. |
| format | Article |
| id | doaj-art-718db2c8824c40e9a3e9a5bd9fe294ca |
| institution | Kabale University |
| issn | 0125-9326 2338-2732 |
| language | English |
| publishDate | 2017-05-01 |
| publisher | Interna Publishing |
| record_format | Article |
| series | Acta Medica Indonesiana |
| spelling | doaj-art-718db2c8824c40e9a3e9a5bd9fe294ca2025-08-20T03:51:35ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322017-05-01491188The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic ReviewRaksheeth Agarwal0Mardiastuti H Wahid1Oliver E Yausep2Sharon Hanmy Angel3Angga W Lokeswara4Faculty of Medicine Universitas Indonesia, Jakarta, IndonesiaDepartment of Microbiology, Faculty of Medicine Universitas Indonesia, Jakarta, IndonesiaFaculty of Medicine Universitas Indonesia, Jakarta, IndonesiaFaculty of Medicine Universitas Indonesia, Jakarta, IndonesiaFaculty of Medicine Universitas Indonesia, Jakarta, IndonesiaAim: to assess the immunogenicity and safety of CYD-tetravalent dengue vaccine (CYD-TDV) in children. Methods: comprehensive literature searches were conducted on various databases. Randomized-controlled trials on children with CYD-TDV as intervention were selected based on inclusion and exclusion criteria. Data extracted from selected trials included safety of vaccine and immunogenicity in terms of Geometric Mean Titres (GMT) of antibodies. Results: six clinical trials were selected based on preset criteria. GMT values were obtained using 50% Plaque Reduction Neutralization Test (PRNT) and safety was semi-quantitatively assessed based on adverse effects. Additional data processing was done to obtain a better understanding on the trends among the studies. The results showed that the groups vaccinated with CYD-TDV showed higher immunogenicity against dengue virus antigens than the control groups. Safety results were satisfactory in all trials, and most severe side effects were unrelated to the vaccine. Conclusion: CYD-TDV is both effective and safe for patients in endemic regions. This gives promise for further development and large-scale research on this vaccine to assess its efficacy in decreasing dengue prevalence, and its pervasive implementation in endemic countries, such as Indonesia.https://www.actamedindones.org/index.php/ijim/article/view/297DengueImmunogenicitySafetyCYD-TDVVaccine |
| spellingShingle | Raksheeth Agarwal Mardiastuti H Wahid Oliver E Yausep Sharon Hanmy Angel Angga W Lokeswara The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review Acta Medica Indonesiana Dengue Immunogenicity Safety CYD-TDV Vaccine |
| title | The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review |
| title_full | The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review |
| title_fullStr | The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review |
| title_full_unstemmed | The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review |
| title_short | The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review |
| title_sort | immunogenicity and safety of cyd tetravalent dengue vaccine cyd tdv in children and adolescents a systematic review |
| topic | Dengue Immunogenicity Safety CYD-TDV Vaccine |
| url | https://www.actamedindones.org/index.php/ijim/article/view/297 |
| work_keys_str_mv | AT raksheethagarwal theimmunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT mardiastutihwahid theimmunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT olivereyausep theimmunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT sharonhanmyangel theimmunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT anggawlokeswara theimmunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT raksheethagarwal immunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT mardiastutihwahid immunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT olivereyausep immunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT sharonhanmyangel immunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview AT anggawlokeswara immunogenicityandsafetyofcydtetravalentdenguevaccinecydtdvinchildrenandadolescentsasystematicreview |